Clinical Trials/JPRN-UMIN000002674

JPRN-UMIN000002674

Completed

Phase 4

A pilot study on the safety and efficacy of an antithrombotic therapy during carotid artery stenting (CAS). - SAITAMA-CAS:A pilot study on the safety and efficacy of an anti-thrombotic treatment in accordance with a CAS

Saitama medical university international medical center Department of Endovascular Neurosurgery0 sites50 target enrollmentFebruary 1, 2010

ConditionsThose patients who have stenosis of more than 50% of the common carotid artery or internal carotid artery (diagnosed by ultrasonography or angiography), with neurological symptoms (transient cerebral ischemic stroke or cerebral stroke), or who have stenosis of more than 80% of the common carotid artery or internal carotid artery (diagnosed by ultrasonography or angiography) even if there are no neurological symptoms.

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Those patients who have stenosis of more than 50% of the common carotid artery or internal carotid artery (diagnosed by ultrasonography or angiography), with neurological symptoms (transient cerebral ischemic stroke or cerebral stroke), or who have stenosis of more than 80% of the common carotid artery or internal carotid artery (diagnosed by ultrasonography or angiography) even if there are no neurological symptoms.
Sponsor: Saitama medical university international medical center Department of Endovascular Neurosurgery
Enrollment: 50
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

February 1, 2010

End Date

February 1, 2012

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Saitama medical university international medical center Department of Endovascular Neurosurgery

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1Ischemic stroke within previous 48 hr 2Presence of intraluminal thrombus 3Total occlusion of target vessel 4Intracranial aneurysm \> 9 mm in diameter 5Need for more than two stents 6History of bleeding disorder 7Percutaneous or surgical intervention planned within next 30 days 8Life expectancy \< 1 year 9Ostial lesion of common carotid artery 10Ostial lesion of brachiocephalic artery 11Contraindication of Pletaal 12Contraindication of Aspirin

Outcomes

Primary Outcomes

Not specified

Similar Trials

Investigation for safety and efficacy of a new antiseptic Olanexidine Gluconate in childrePatients who undergo surgery of catheter insertion or inguinal hernia

JPRN-UMIN000027899ational Center for Child Health and Development55

Active, not recruiting

Breast Cancer - Anti-Progestin Prevention Study 1We seek to investigate the breast cancer risk reducing properties of ulipristal acetateMedDRA version: 20.1Level: PTClassification code 10004746Term: Biopsy breast normalSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10071224Term: Breast scanSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Cancer [C04]

EUCTR2015-001587-19-GBManchester University NHS Foundation Trust30

Breast Cancer - anti-progestin prevention study 1Malignant neoplasm of breastCancer

ISRCTN15575894niversity Hospital of South Manchester30

A clinical study of the safety and efficacy of anti-epileptic drug Zonisamide for treatment of radiculopatyCervical spondylotic radiculopathyCervical spondylotic radiculopathy, cervical disc hernia, sensory impairmentD011843

JPRN-jRCTs041210043Imagama Shiro24

Evaluation of safety and effectiveness of Prim anti-dandruff linehair Dandruff.hair Dandruff

IRCT20150101020514N14Akhavi laboratory28